The search combined Medical Subject Headings (MeSH) and free-text terms: ("sodium-glucose transporter 2 inhibitors" OR "SGLT2 inhibitors" OR "dapagliflozin" OR "empagliflozin" OR "canagliflozin" OR "ertugliflozin" OR "ipragliflozin" OR "luseogliflozin" OR "tofogliflozin") AND ("non-alcoholic fatty liver disease" OR "NAFLD" OR "nonalcoholic fatty liver" OR "fatty liver" OR "hepatic steatosis") AND ("diabetes mellitus, type 2" OR "type 2 diabetes" OR "T2DM"). This evidence concerns the gene SLC5A2 and fatty liver disease.